Registry of Catheter Intervention in Pulmonary Embolism

Conditions

Pulmonary Embolism, Pulmonary Embolism Acute, Pulmonary Embolism Acute Massive, Pulmonary Embolism and Thrombosis, Pulmonary Thromboembolisms

Keywords

Aspiration Thrombectomy, Percutaneous Aspiration Thrombectomy, Local Thrombolysis

Brief summary

Multicenter longitudinal observational ambispective (retrospective cases from 2014 and prospective from 2018 onwards) cohort study. The registry recruits a series of consecutive patients admitted for moderate-high risk or high-risk pulmonary embolism (according to 2019 European Society of Cardiology guidelines) treated invasively. This study aims to describe the acute management of the safety and effectiveness of different percutaneous interventions for acute pulmonary embolism.

Alejandro Lara García, Daniel Tébar Márquez, Carlos Real, Pablo Salinas, Gonzalo García‐Martí et al. (12 authors)

Journal of Clinical Medicine2026-09-14

10.3390/jcm15187135

New risk classification adapting SCAI shock stages to patients with pulmonary embolism (RISA-PE).

Párraga R, Real C, Jiménez-Mazuecos J, Vázquez-Álvarez ME, Valero E, Velázquez M, Tébar D, Salvatella N, Rumiz E, Ruiz Quevedo V, Sabatel-Pérez F, Amat-Santos I, Lozano I, Elizondo I, Andrés-Morist A, Núñez-Gil I, Portero JJ, Gonzalo N, Juárez Fernández M, Viana-Tejedor A, Ferrera C, Salinas P.

2024-09-244 citations

10.23736/s2724-5683.24.06609-2

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* adult patients (aged 18 years old or older) * confirmed diagnosis of acute PE (on computed tomography or echocardiogram plus pulmonary angiography) * high-risk PE or intermediate-high risk according to ESC risk stratification in the 2019 guidelines (briefly, elevated cardiac biomarkers \[troponin or N-terminal pro-B-type natriuretic peptide\], and right ventricle to left ventricle ratio \> 0.9 \[on computed tomography or echocardiogram\], and PE severity index III to IV or simplified PE severity index=1 * eligibility for catheter-directed intervention

Exclusion criteria

* unconfirmed diagnosis of PE * undefined risk stratification, and * PE with uncertain chronology or beyond seven days of symptom initiation.

Design outcomes

Primary

Measure	Time frame
All cause-death	during hospital admission (up to day 10)

Secondary

Measure	Time frame	Description
all cause-death	48 hours	—
procedural success	48 hours	defined as technical procedure completed without procedural complications or 48-hour death
in-hospital complications	during hospital admission (up to day 10)	—

Countries

Spain

Contacts

Primary ContactPablo Salinas, MD, PhD

salinas.pablo@gmail.com+34 913303000

Outcome results